INMD241220P29000
- 0.00
- 0.000.00%
InMode Newsroom
Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
The Returns On Capital At InMode (NASDAQ:INMD) Don't Inspire Confidence
InMode's (NASDAQ:INMD) Earnings Have Declined Over Three Years, Contributing to Shareholders 77% Loss
Is InMode Ltd. (NASDAQ:INMD) Trading At A 47% Discount?
InMode (NASDAQ:INMD) Might Be Having Difficulty Using Its Capital Effectively
InMode to Present at Upcoming Investor Conferences
We Think You Can Look Beyond InMode's (NASDAQ:INMD) Lackluster Earnings
UBS Adjusts Price Target on InMode to $19 From $17, Maintains Neutral Rating
InMode Analyst Ratings
Needham Maintains InMode(INMD.US) With Hold Rating
Hartwater Aesthetics CEO to Deliver Keynote Address at Upcoming Industry Conference
InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript Summary
InMode's Q3 Non-GAAP Earnings, Revenue Increase; Lowers 2024 Revenue Outlook
Express News | Inmode Ltd: Full-Year 2024 Revenue Guidance Has Been Revised to Be Between $410 Mln and $420 Mln
InMode Cuts FY24 View To Rev $410M-$420M >INMD
InMode: Q3 Earnings Snapshot
Earnings Flash (INMD) INMODE Posts Q3 EPS $0.70
InMode Non-GAAP EPS of $0.70 Beats by $0.09, Revenue of $130.23M Beats by $3.32M
InMode | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | Inmode Reports Third Quarter 2024 Financial Results; Quarterly Gaap Revenue of $130.2 Million (Which Consists of $98.3 Million of Net Sales in Q3 and $31.9 Million of Pre-Orders From the First Half of 2024)